Females experience a more severe disease course in Batten disease
- PMID: 22167274
- PMCID: PMC3320704
- DOI: 10.1007/s10545-011-9421-6
Females experience a more severe disease course in Batten disease
Erratum in
- J Inherit Metab Dis. 2012 May;35(3):559
Abstract
Juvenile neuronal ceroid lipofuscinosis (JNCL; CLN3 disease; Batten disease) is an autosomal recessive neurodegenerative disease of childhood. Symptoms typically present at school age with vision loss followed by progressive cognitive decline, motor dysfunction, seizures, and behavior problems. Studies on sex differences in JNCL have yielded mixed results, but parent anecdotes suggest that females experience a more precipitous disease course. Therefore, we sought to determine if sex-based differences exist in JNCL. We used data from the Unified Batten Disease Rating Scale (UBDRS), the Batten Disease Support and Research Association (BDSRA) database, and the PedsQL quality of life (QoL) survey to evaluate sex-based differences in functional independence and time from symptom onset to death. On average, females had JNCL symptom onset one year later and death one year earlier than did males. Despite a later age at onset, females had lower functional capability, earlier loss of independent function, and lower physical QoL. Future research in sex differences in JNCL may help to further understand the biological mechanisms underpinning the disease course and may point to targeted therapies.
Figures









Similar articles
-
Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data.J Inherit Metab Dis. 2011 Oct;34(5):1075-81. doi: 10.1007/s10545-011-9346-0. Epub 2011 May 10. J Inherit Metab Dis. 2011. PMID: 21556831 Free PMC article.
-
Do females with juvenile ceroid lipofuscinosis (Batten disease) have a more severe disease course? The Danish experience.Eur J Paediatr Neurol. 2013 May;17(3):265-8. doi: 10.1016/j.ejpn.2012.10.011. Epub 2012 Nov 21. Eur J Paediatr Neurol. 2013. PMID: 23177590
-
The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample.Eur J Paediatr Neurol. 2022 May;38:62-65. doi: 10.1016/j.ejpn.2022.03.005. Epub 2022 Apr 4. Eur J Paediatr Neurol. 2022. PMID: 35427884 Free PMC article.
-
Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.Int J Mol Sci. 2020 Oct 29;21(21):8055. doi: 10.3390/ijms21218055. Int J Mol Sci. 2020. PMID: 33137890 Free PMC article. Review.
-
Timing of cognitive decline in CLN3 disease.J Inherit Metab Dis. 2018 Mar;41(2):257-261. doi: 10.1007/s10545-018-0143-x. Epub 2018 Feb 1. J Inherit Metab Dis. 2018. PMID: 29392585 Free PMC article.
Cited by
-
A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes.Dis Model Mech. 2023 Aug 1;16(8):dmm050038. doi: 10.1242/dmm.050038. Epub 2023 Aug 7. Dis Model Mech. 2023. PMID: 37305926 Free PMC article.
-
Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures.J Inherit Metab Dis. 2021 Jul;44(4):1013-1020. doi: 10.1002/jimd.12366. Epub 2021 Feb 15. J Inherit Metab Dis. 2021. PMID: 33550636 Free PMC article.
-
Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system.PLoS One. 2012;7(6):e38310. doi: 10.1371/journal.pone.0038310. Epub 2012 Jun 6. PLoS One. 2012. PMID: 22701626 Free PMC article.
-
Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review.Orphanet J Rare Dis. 2018 Nov 28;13(1):215. doi: 10.1186/s13023-018-0953-9. Orphanet J Rare Dis. 2018. PMID: 30486833 Free PMC article.
-
A recessive CLN3 variant is responsible for delayed-onset retinal degeneration in Hereford cattle.J Vet Diagn Invest. 2024 May;36(3):438-446. doi: 10.1177/10406387241239918. Epub 2024 Mar 22. J Vet Diagn Invest. 2024. PMID: 38516801 Free PMC article.
References
-
- Aberg LE, Tiitinen A, Åutti TH, Kivisaari L, Santavouri P. Hyperandrogenism in girls with juvenile neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol. 2002;6:199–205. - PubMed
-
- Bäckman ML, Santavuori PR, Åberg LE, Aronen ET. Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis. J Intellect Disabil Res. 2005;49:25–32. - PubMed
-
- Boustany R-M. Batten disease or neuronal ceroid lipofuscinosis. In: Moser HW, editor. Handbook of clinical neurology. 66. Vol. 22. Elsevier Science B.V; 1996. pp. 671–700.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources